Related Experiment Video
Updated: Jul 17, 2026

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
Published on: December 15, 2017
Optimization of protein expression systems for modern drug discovery
Michael Forstner1, Lukas Leder, Lorenz M Mayr
1Protein Expression & Purification Novartis Institutes of BioMedical Research, Discovery Technologies/Lead Discovery Center CH-4002 Basel, Switzerland. michael.forstner@novartis.com
Abstract:
The expression of high levels of stable and functional proteins remains a bottleneck in many scientific endeavors, including the determination of structures in a high-throughput fashion or the screening for novel active compounds in modern drug discovery. Recently, numerous developments have been made to improve the production of soluble and active proteins in heterologous expression systems. These include modifications to the expression constructs, the introduction of new and/or improved pro- and eukaryotic expression systems, and the development of improved cell-free protein synthesis systems. The introduction of robotics has enabled a massive parallelization of expression experiments, thereby vastly increasing the throughput and, hopefully, the output of such experiments. In addition, the big challenges of recombinant overexpression of membrane and secreted proteins are tackled, and some new methods are reviewed.
Related Concept Videos
Upstream Processing
Drug Discovery: Overview
Bioreactor Controls-III

